Mesenchymal Stem Cells May Ameliorate Nephrotic Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation-Case Report

Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice

(2016) H. Jin et al.   BLOOD

The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation

(2016) Ke Zhao et al.   Journal of Hematology & Oncology

Aberrant B-cell homeostasis in chronic GVHD

(2015) S. Sarantopoulos et al.   BLOOD

CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease

(2015) A. de Masson et al.   BLOOD

Regulatory T cells and minimal change nephropathy: in the midst of a complex network

(2015) R. Bertelli et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The regulatory role of B cells in autoimmunity, infections and cancer: Perspectives beyond IL10 production

(2015) Melisa Gorosito Serrán et al.   FEBS LETTERS

Increased BCR responsiveness in B cells from patients with chronic GVHD

(2014) Jessica L. Allen et al.   BLOOD

Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10

(2014) Y Peng et al.   LEUKEMIA

Cellular targets of regulatory B cell-mediated suppression

(2014) Elizabeth C. Rosser et al.   MOLECULAR IMMUNOLOGY

Alteration of Naïve and Memory B-Cell Subset in Chronic Graft-Versus-Host Disease Patients After Treatment With Mesenchymal Stromal Cells

(2014) Yanwen Peng et al.   Stem Cells Translational Medicine

Protective effects of mesenchymal stromal cells on adriamycin-induced minimal change nephrotic syndrome in rats and possible mechanisms

(2013) Junqi Guo et al.   CYTOTHERAPY

Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study

(2013) Hui Liu et al.   Journal of Hematology & Oncology

Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants

(2012) Jianming Tan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans

(2011) M. Srinivasan et al.   BLOOD

Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesis

(2011) Xiao-dan Luo et al.   BLOOD CELLS MOLECULES AND DISEASES

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

(2010) J Y Weng et al.   BONE MARROW TRANSPLANTATION

B-Cell–Depleting Induction Therapy and Acute Cellular Rejection

(2009) Menna R. Clatworthy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunomodulatory Properties of Mesenchymal Stromal Cells and Their Therapeutic Consequences for Immune-Mediated Disorders

(2009) Senming Zhao et al.   STEM CELLS AND DEVELOPMENT